about
Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs.Tuberculosis and illicit drug use: review and update.Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.The rational use of potentially hepatotoxic medications in patients with underlying liver disease.Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.Severe hepatic complications of antituberculous therapyLiver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure: A Case Report and Review of the Literature.Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment.Hepatotoxicity of antituberculosis drugs.Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.Hepatotoxicity of antituberculosis drugs.The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor.Monitoring and management of antituberculosis drug induced hepatotoxicity.Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.Hepatotoxic effects of tuberculosis therapy.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Liver transplantation for acute liver failure due to antitubercular drugs – a single-center experience.
P2860
Q32061381-FFE8C073-1E90-4408-9E6F-D3D68BEB9F6DQ34601143-7B4DD53A-9163-48B1-8C08-BE0D8F12C454Q35010245-880782F6-A2C8-47DA-8E44-66AE7260B3F8Q35194515-E87EA166-DE22-416B-93F0-FE431F8F616AQ35579265-4E82BA59-D15C-4371-A232-166DF8979365Q35649646-39EA24AF-85ED-48B3-B66A-08EE61CDA5CCQ37225859-CDADA63D-0213-455B-819A-E46AFEA847AAQ39068129-AB7DA44F-EDA4-4FBD-B37B-463231414865Q42422791-E9D88E20-4A3C-45D1-AF78-3271EBF8F5D3Q43145214-E10E50E8-8978-45C6-9869-4F87A332E2CAQ43279092-07071384-EA5A-4AB3-9172-5195F0E404FEQ43708313-83B7F336-6110-40F8-A5B4-EFE75B2F17AFQ44294261-CC8D49F1-85F8-44C7-8992-C1AA1DADE603Q45755625-4BBCBABF-0CFC-4822-BE35-F2D25D9C747CQ45909196-364D7FAD-665E-47FF-BB4C-D5F9CD0EFD92Q49967277-F437040B-E4C3-4E5B-B79F-A94C326F727EQ52625145-D06D3139-9D01-43D4-ABF2-154E162B0886Q55268147-2974BD60-8B45-4177-91D2-6374BAB03E7F
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Anti-tuberculous therapy and acute liver failure.
@en
type
label
Anti-tuberculous therapy and acute liver failure.
@en
prefLabel
Anti-tuberculous therapy and acute liver failure.
@en
P2093
P1433
P1476
Anti-tuberculous therapy and acute liver failure
@en
P2093
P304
P356
10.1016/S0140-6736(95)90468-9
P407
P577
1995-03-01T00:00:00Z